Screening for mild cognitive impairment: a systematic review
✍ Scribed by Jane A. Lonie; Kevin M. Tierney; Klaus P. Ebmeier
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 250 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0885-6230
- DOI
- 10.1002/gps.2208
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Objective
Patients with mild cognitive impairment account for a significant number of referrals to old age psychiatry services and specialist memory clinics. The cognitive evaluation of such patients is commonly restricted to brief dementia screens, with no consideration to their suitability for assessing MCI. Here, we review the utility of such cognitive screens for MCI and provide an overview of validated instruments.
Methods
We identified papers published after Petersen and colleagues 1999 MCI criteria (Petersen et al., 1999) and examining face‐to‐face cognitive screening for MCI from publication databases using combinations of the search terms ‘mild cognitive impairment’ and ‘cognitive screening’. We also combined the former search with the names of 39 screening tests recently identified in a relevant review (Cullen et al., 2007).
Results
Fifteen cognitive screening instruments were identified, 11 cover a restricted range of cognitive domains. High sensitivity and specificity for MCI relative to healthy controls were reported for two comprehensive and two noncomprehensive screening instruments, adequate test‐retest and inter‐rater reliability for only one of these. With the exception of three studies, sample sizes were universally small (i.e. n ≤ 100), and prognostic values were reported for only two of the identified 15 screening measures. Sensitivities of the full domain measures were universally high, but information about their specificity against psychiatric and non‐progressive neurological conditions and predictive validity is lacking.
Conclusion
Several cognitive screening instruments afford the clinician the ability to detect MCI, early AD, and in some cases non‐AD dementia, but they cannot currently be used to make reliable inferences about the course and eventual outcome of MCI. Copyright © 2009 John Wiley & Sons, Ltd.
📜 SIMILAR VOLUMES
## Abstract ## Background Several factors have prompted renewed interest in the concept of declines in cognitive function that occur in association with aging, in particular the area between normal cognition and dementia. We review the changing conceptualization of what has come to be known as mil
A correct balance between endocannabinoid and dopamine-dependent systems is believed to underlie physiological motor control. We measured the levels of the endocannabinoid anandamide in the cerebrospinal fluid of Parkinson's disease (PD) patients. Subjects were divided into three groups: newly diagn
## Objective: To test correctness of results when combining mini-mental state examination (mmse) and cognitive capacity screening examination (ccse) for identifying mild cognitive impairment (mci) among non-demented elderly subjects at risk for developing dementia. ## Methods: A retrospective stu
## Abstract ## Objective To screen for cognitive assessment for patients with vascular cognitive impairment (VCI) no dementia (V‐CIND) from a set of cognitive measures. ## Methods Extensive neuropsychological tests covering five cognitive domains were performed on 80 V‐CIND patients and 80 norma
## Abstract ## Background Early dementia diagnosis is aided by the use of brief screening tests; scores can be biased by patient and informant characteristics such as age, gender and education. ## Objective To assess whether the General Practitioner's Assessment of Cognition (GPCOG), a brief scr